| Literature DB >> 21859467 |
Morten R Clausen1, Kirstine L Christensen, Mette S Hedemann, Ying Liu, Stig Purup, Mette Schmidt, Henrik Callesen, Jan Stagsted, Hanne C Bertram.
Abstract
BACKGROUND: Pigs are widely used as models for human physiological changes in intervention studies, because of the close resemblance between human and porcine physiology and the high degree of experimental control when using an animal model. Cloned animals have, in principle, identical genotypes and possibly also phenotypes and this offer an extra level of experimental control which could possibly make them a desirable tool for intervention studies. Therefore, in the present study, we address how phenotype and phenotypic variation is affected by cloning, through comparison of cloned pigs and normal outbred pigs.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21859467 PMCID: PMC3174869 DOI: 10.1186/1472-6793-11-14
Source DB: PubMed Journal: BMC Physiol ISSN: 1472-6793
Figure 1NMR spectra and assignments. Representative 1H NMR spectra of bile, plasma and urine obtained from a cloned pig. All spectra were acquired on a 600 MHz spectrometer. Less abundant amino acids (Glu, Gln, Lys, and Arg) with complex spectra could not be unambiguously assigned in the spectral region 1.6 - 2.6 ppm in urine. Assignments: 1, bile acids, cholesterol; 2, lipids (-CH2-); 3, bile acids cholesterol, lipids; 4, bisallyllic protons; 5, conjugated taurine; 6, choline or phosphatidylcholine (PC) (-N-(CH3)3); 7, glycine/taurine conjugated cholate (CA), glycine/taurine conjugated chenodeoxy cholate (CDCA); 8, Conjugated deoxycholate (H-3β), conjugated taurine (H-25); 9, PC (CH2-N); 10, Conjugated glycine (H-25); 11, conjugated cholate and deoxycholate, PC-glycerol (3-CH2); 12, PC-glycerol (1-CH); 13, PC (-O-CH2-); 14, CH = CH, cholesterol (6-CH), PC-glycerol (2-CH); 15; Conj bile acids (-NH-); 16, LDL/VLDL; 17, leucine; 18, valine; 19, isoleucine; 20, lactate; 21, alanine; 22, adipate; 23, acetate; 24, N-acetyl glycoproteins; 25, O-acetyl glycoproteins; 26, glutamine/glutamate; 27, pyruvate; 28, glutamate; 29, creatine; 30, choline; 31, trimethylamine-N-oxide (TMAO); 32, glucose; 33, creatinine; 34, tyrosine; 35, phenylalanine; 36, isovaleraldehyde; 37, α-hydroxyisobutyrate; 38, unknown; 39, citrate; 40, dimethylamine; 41, trimethyl amine; 42, taurine; 43, glycine; 44, phenylacetylglycine; 45, hippurate; 46, unknown; 47, alantoin; 48, urea; 49, unknown; 50, guanine. For further information about identified metabolites, please refer to Additional file 1
Figure 2Urine PCA. PCA score plots of urine samples from cloned pigs (closed symbols) and control pigs (open symbols). n = 11. Cumulated explained variance, R= 0.57, Cumulated cross validated explained variance, Q(cum) = -0.17 for the three component model made from normalized data.
Figure 3Bile PCA. PCA score plot of bile samples from cloned pigs (closed symbols) and control pigs (open symbols) (a) and PC1 loading plot (b). n = 11. R= 0.57, Q(cum) = 0.36 for the one component model. For visualization principal component 2 is shown in the score plot. Major discriminatory resonances are marked with numbers that correspond to the identifications in figure 1.
Figure 4Plasma PCA. PCA score plot of plasma samples from cloned pigs (closed symbols) and control pigs (open symbols) (a) and PC2 loading plot (b). n = 112. R= 0.97, Q(cum) = 0.74 for the 10 component model. Major discriminatory resonances are marked with numbers that correspond to the identifications in figure 1. Asterisk denotes presumed threonine, which could not be resolved in the 1-D NMR spectrum.
PCA models for NMR spectral data
| Bio-fluid | Normalization | n | Number of components | R2X | Q2 (cum) |
|---|---|---|---|---|---|
| Bile | + | 11 | 1 | 0.57 | 0.36 |
| Bile | -a | 11 | 2 | 0.40 | 0.37 |
| Urine | + | 11 | 3 | 0.57 | -0.17 |
| Urine | - | 11 | 2 | 0.39 | 0.12 |
| Plasma | + | 110 | 10 | 0.97 | 0.74 |
| Plasma | - | 110 | 10 | 0.95 | 0.91 |
Summary of PCA models of all biofluids, with and without normalization
aFirst component was used to describe the variation induced by one outlier. This outlier was included in the analysis, since the second component, which described the difference between groups, was not affected by it.
Figure 5Plasma O-PLS. O-PLS score plot of all plasma samples from cloned pigs (closed symbols) and control pigs (open symbols) (a) and S-plot for plasma metabolites (b). R2X = 0.72, R2Y = 0.83, Q2(cum) = 0.65. Variables with high discriminatory ability are identified in the S-plot and metabolites related to these variables are enlarged and coded with colours according to the legend. For clarity other variables are shown as dots.
Relative areas of selected metabolites in plasma determined by NMR integrals
| Compound | Observed δ, ppm | Clone | Control | ||||
|---|---|---|---|---|---|---|---|
| Alanine | 1.48 | 7.7 | ± | 0.5 | 6.8 | ± | 0.2 |
| Choline | 3.21 | 16 | ± | 1.2 | 19 | ± | 2.0 |
| Creatine | 3.92 | 3.1 | ± | 0.4 | 5.2 | ± | 0.7 |
| Glutamate | 2.45 | 8.2 | ± | 0.2 | 7.5 | ± | 0.1 |
| Lactate | 4.11 | 26 | ± | 4.7 | 15 | ± | 2.0 |
| Lipid | 5.30 | 18.5 | ± | 0.9 | 22 | ± | 1.2 |
| VLDL/LDL | 0.85 | 64 | ± | 4.6 | 77 | ± | 3.5 |
| VLDL/LDL | 1.25 | 89 | ± | 5.2 | 109 | ± | 3.4 |
Results are reported as mean ± standard deviation. Cloned pigs (n = 5) and control pigs (n = 6). All metabolites were significantly different between the two groups with p < 0.001.
Variances calculated for integrals from bile, plasma, and urine
| Variance | ||||||
|---|---|---|---|---|---|---|
| Peak number | Biofluid | Observed δ, ppm | Signal range | Clone | Control | v clone/v control |
| Bile | 0.62 | 87 - 102 | 5, 98 | 39.1 | 0.15 | |
| Bile | 2.75 | 2.9 - 14.7 | 1.60 | 0.89 | 1.80 | |
| Bile | 3.45 | 8.5 - 13.5 | 0.60 | 5.82 | 0.048a | |
| Bile | 7.80 | 13.8 - 18.0 | 0.19 | 1.26 | 0.15 | |
| Bile | 7.98 | 1.8 - 4.9 | 0.57 | 2.15 | 0.26 | |
| Bile | 3.07 | 5.9 - 16.8 | 7.03 | 12.5 | 0.56 | |
| Bile | 4.30 | 3.7 - 8.5 | 0.94 | 0.74 | 1.27 | |
| 4.42 | 0.5 - 3.8 | 0.049 | 0.036 | 1.38 | ||
| 3.25 | 12 - 53 | 15.2 | 7.05 | 2.16 | ||
| Plasma | 1.91 (s) | 0.005 - 0.05 | 5.40E-5 | 4.47E-5 | 1.21 | |
| Plasma | 1.47 (d) | 0.006 - 0.1 | 0.00038 | 0.00037 | 1.02 | |
| Plasma | 4.04 (s) | 0 - 0.03 | 2.77E-5 | 4.38E-5 | 0.63 | |
| Plasma | 4.10 (q) | 0.03 - 0.7 | 0.013 | 0.017 | 0.78 | |
| Plasma | 2.36 (s) | 0.003 - 0.04 | 4.54E-5 | 3.37E-5 | 1.35 | |
| Plasma | 7.18 (d) | 0.003 - 0.03 | 3.12E-5 | 3.32E-5 | 0.94 | |
| Plasma | 1.03 (d) | 0.004 - 0.3 | 0.0018 | 0.00038 | 4.58a | |
| Urine | 1.48 (d) | 0.82 - 7.44 | 2.2 | 2.5 | 0.87 | |
| Urine | 5.39 (s) | 1.89 - 31.4 | 112 | 53 | 2.11 | |
| Urine | 3.04 (s) | 44 - 497 | 2.4E4 | 6.5E3 | 3.75 | |
| Urine | 4.05 (s) | 31 - 349 | 1.2E4 | 3.2E3 | 3.69 | |
| Urine | 7.84 (d) | 3.6 - 40 | 138 | 61 | 2.26a | |
| 7.55 (t) | 3.7 - 47 | 185 | 67 | 2.85a | ||
| 3.97 (m) | 8.0 - 87 | 524 | 178 | 2.94a | ||
| 7.64 (t) | 8.1 - 28 | 64 | 19 | 3.44a | ||
| Urine | 0.94 (d) | 2.8 - 18 | 23 | 14 | 1.61 | |
| Urine | 1.36 (s) | 2.9 - 11 | 7.2 | 4.0 | 1.80 | |
| Urine | 7.37 (m) | 1.8 - 17 | 5.7 | 30.1 | 0.19 | |
| Urine | 7.23 (d) | 2.2 - 68 | 547 | 181 | 3.02 | |
| Urine | 7.06 (d) | 0.7 - 60 | 514 | 146 | 3.52 | |
| Urine | 5.08 (d) | 0.0 - 22.1 | 79 | 15 | 5.20 | |
| Urine | 5.78 | 78 - 643 | 2.0E4 | 1.2E4 | 1.62 | |
Variances based on normalized urine spectra and raw bile and plasma spectra. For each metabolite the ratios between cloned pig variances and control pig variances are shown. Peak numbers refer to the legend in Figure 1
a, significant values.